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ABSTRACT
Diphyllin and its derivatives are well known cytotoxic natural products structurally 
related to the anti-cancer drug podophyllotoxin. We here study their structure-activity 
relationship upon human melanoma cells for first time. To this end, human melanoma 
A375 cells were incubated with Justicidin B and its 4-methoxylated or 4-glycosylated 
derivatives to evaluate their selective cytotoxicity and study their effects on cell 
cycle distribution, caspase activation, apoptosis induction using Annexin V-FITC/PI 
staining, cell morphology and western blot analysis. Diphyllin methyl ether (GI50 = 
3.66 μM) and Justicidin B (GI50 = 1.70 μM) caused an elevation of both early and late 
apoptosis populations whereas Diphyllin apioside (GI50 = 0.84 μM) and its acetate 
(GI50= 0.39 μM) enhanced late apoptosis population only (Annexin V-positive/PI-
positive). All induced cell cycle arrest at S phase and classic morphological indicators 
of apoptosis (blebbing, apoptotic bodies, and nuclear fragmentation) accompanied 
with an elevation of cells with low DNA content (sub-G1). All compounds increased 
the Bax/Bcl-2 ratio by enhancing Bax expression which evidences the involvement 
of the mitochondria (intrinsic pathway) in the apoptotic process. These caspase-3/7 
results evidence that 4-methoxylation or 4-O-glycosylation of Justicidin B -a caspase 
independent mitochondrial apoptosis-inducer- triggers caspase-3/7 activation at 
different times (24h vs. 48h, respectively). Interestingly, the methoxylation causes 
attenuation of Bcl-2 protein expression contrarily to Diphyllin methyl ether or the 
O-glycosylated derivatives. Finally, the compounds exhibited significantly less toxicity 
when tested in adult human dermal fibroblasts and their GI50 in melanoma Sk-Mel-5 
cells was not influenced by MDR1/Pgp inhibitors. This study may inform the synthesis 
of future Diphyllin derivatives with different apoptosis mechanism of action towards 
human melanoma cells.
INTRODUCTION
Justicidin B (Figure 1) is a naturally occurring 
cytotoxic arylnaphtalene lignan endowed with powerful 
bioactivities [1]. Its structure is closely related to the 
well known anti-cancer drug podophyllotoxin and its 
derivatisation in position 4 gives Diphyllin and other 
derivatives, which retain the marked cytotoxic activity of 
the parent molecule. Justicidin B and its derivatives have 
been isolated from Haplophyllum tuberculatum and other 
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species such as Justicia procumbens which both have been 
used traditionally in the treatment of cancer [2, 3].
The cytostatic activities of Diphyllin and some of 
its derivatives were described in 1979 by González et al. 
[4] who adscribed them to their ability to block the DNA 
synthesis in both normal and malignant cells pointing 
to an intercalating action in the minor groove. Later on, 
the authors claimed that Diphyllin itself have no value as 
anti-cancer drug, first because its negative cytotoxic index 
-high tocixicity on both cancer and human primary cells. 
Figure 1: Chemical structures of (A) Diphyllin, R= OH; Justicidin B, R=H; Diphyllin methyl ether, R= OCH3; Diphyllin 
apioside, R= O-apioside; Diphyllin acetylapioside, R= O-5’’-acetylapioside, (B) Podophyllotoxin.
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Modern studies pointed that its anti-proliferative action 
on cancer cells may involve the cell cycle arrest in the 
S-phase and inhibition of protein synthesis [5] but also 
cytotoxic activity towards human monocytes and skin 
tissues [6] and that it is effluxed by P-glycoprotein (P-
gp) [7], thus limiting its therapeutic potential. However, 
glycosilation may revert the negative cytotoxic index as in 
the case podophyllotoxin/etoposide. In fact, Cleistanthin 
A (diphyllin O-(3,4-Di-O-methyl-D-xylopyranoside) is 
reported to be more toxic to cancer cells than to normal 
ones [8, 9].
Later work on these class of compounds have 
reported cytotoxicity mostly at low micromolar range in 
other cell lines such as human cervical cancer (HeLa 229) 
[10], human hepatoma (Hep 3B and Hep G2) [11], human 
colon cancer (HT-29, HCT 116;) and breast cancer (MCF-
7) [12] cell lines. Justicidin B was cytotoxic to acute 
myeloid leukemia (HL-60) [13], breast cancer cell line 
(MCF-7) [14], human cervical cancer cells (HeLa 229) 
[10], chronic myeloid leukemia (LAMA-8 and K-562) 
and chronic lymphoid leukemia (SKW-3) [15] cell lines. 
Diphyllin apioside, has been reported to have cytotoxic 
activities against the hepatoma cells (Hep3B), breast 
cancer cells (MCF-7, MCF-7-ras), human cervical cancer 
cells (SiHa), human colon cancer cells (HT-29, HCT 116) 
[16].
Despite all these studies always conclude that 
Justicidin B is a good lead compound for anti-cancer 
activity only one attempt to systematically evaluate the 
structure-activity relationship of its derivatives has been 
published [17]. The authors conclude that hydroxylation in 
position 6 of the D-ring enhances cytotoxicity. However, 
their work analyses the involvement of caspase 3 and 
the cell cyle distribution at 48h only. Importantly, it does 
not evaluate their selectivity –i.e cytotoxicity in normal 
cells- and does not include glycosylated derivatives, 
which potentially may increase both selectivity and 
cytotoxicity as already discussed [8, 9]. Despite a number 
of studies on their in vitro and in vivo cytotoxic activities 
on several cancer cell lines, a systematic comparison of 
the effect of different substitutions upon the mechanism 
of their apopototic effect remains to be done. Moreover, 
crude herbal drugs rich in diphyllin derivatives were 
used since ancient times as topical treatment of warts and 
pigmentation disorders [18] but to this day –and to the best 
of our knowledge- there is not any comparative study of 
their effects upon human melanoma cells or human normal 
skin cells.
We therefore decided to contribute to a better 
knowledge of their structure-activity relationship by 
focusing on the derivatization in position 4 of the B-ring 
by testing Justicidin B, Diphyllin methyl ether and two 
naturally occurring glycosylated derivatives (Diphyllin 
apioside and Diphyllin acetylapioside). Of note, the anti-
proliferative activity of the latter has not been previously 
reported in literature. We used human melanoma cells for 
first time over an extended period of time (24, 48, and 72h 
endpoints), compare their effects to those on adult human 
fibroblasts (48h endpoint) and in addition of caspase-3/7 
we investigate their modulation of Bax/Bcl-2 expressions 
in order to gain further insights into their mechanisms of 
action.
RESULTS
Anti-proliferative activity on human melanoma 
A375 cells and selectivity towards adult human 
dermal fibroblasts (HDF-a)
We present in this paper all results in the form of 
Images and Graphs for convenience. Please download our 
Supplementary Materials for Tables 1-5 containing the 
exact numerical results of each experiment.
The inhibitory effects on A375 cell proliferation 
was assessed by the Sulforhodamine B (SRB) method 
following cell exposure to several concentrations of 
Justicidin B and its derivatives at different time points 24, 
48 and 72h. Figure 2 shows that all compounds inhibited 
the proliferation of A375 cells at time and dose-dependent 
manners as compared to control. The GI50 of Justicidin 
B and Diphyllin methyl ether were found at the low μM 
range, whilst their glycosylated derivatives at the nM 
range.
Human dermal fibroblasts have been consistently 
used as a ‘normal’ cell line closely related to melanoma 
due to their anatomical proximity and functional 
relationship, specially the differential ability of fibroblasts 
to enhance or inhibit the growth of melanoma cells 
depending on their tumor stage [19, 20]. Figure 2 shows 
the inhibitory effects on adult human dermal fibroblasts 
(HDF-a) as assessed by the same method following 48h 
exposure to the compounds. The relative selectivity of 
their anti-proliferative effects were 10 fold for Justicidin 
B (GI50 = 17 μM), 6.8 fold for Diphyllin methyl ether (GI50 
= 25 μM), 3.5 fold for Diphyllin apioside (GI50 = 3 μM) 
and 7.7 fold for Diphyllin acetylapioside (GI50 = 3 μM).
Effects on the human melanoma on A375 cell 
cycle distribution
Quantification of synchronised cells in different 
phases of the cell cycle at 48h was carried out in A375 
cells exposed GI50 concentrations of the compounds using 
flow cytometry to assess whether anti-proliferative activity 
of Diphyllin derivatives results in a change in cell cycle 
profile. As shown in Figure 3, the exposure of A375 cells 
to the compounds resulted in a significant increase of cell 
population at S phase from 16% in untreated cells to 26-
28%. This elevation in S population was associated with a 
concomitant decrease in G1 population up to about 60%. 
Moreover, a significant accumulation of cells at sub-G1 
peak up to 9-13% was detected in all cases.
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Detection of apoptosis induction by Annexin V- 
FITC/ PI staining
Flow cytometry analysis using Annexin V-FITC/PI 
double staining was performed to assess the translocation 
of phosphatidylserine to the outer leaflet of cell membrane 
-a marker of early apoptotic cells [21]- following cell 
exposure to Diphyllin derivatives. Figure 4 shows that 
24h treatment with Justicidin B treatment of A375 cells 
at resulted in a significant enhancement in both early 
(Annexin V-positive/ PI-negative, 2.10%, p = 0.0178) 
and late apoptotic populations (Annexin V-positive/ PI-
Figure 2: Anti-proliferative effect of Diphyllin and derivatives on (A) human melanoma A375 cells and (B) adult Human Dermal 
Fibroblasts (HDF-a) as assessed by the SRB assay (24, 48 and 72h). Results are shown as mean ± SD (n=3).
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positive, 12.71%, p = 0.0435). Diphyllin methyl ether 
markedly increased early apoptotic cells 6.70% compared 
to control 1.03% (p = 0.0420). The total percent of late 
apoptotic cells was also elevated from 4.22% up to 
10.38% (p = 0.0373) and the number of viable cells was 
significantly reduced (78.56% p = 0.0096) in comparison 
to untreated cells (88.46%) without a significant change in 
the number of PI-positive population.
The percentage of viable cells was significantly 
reduced to 60.93% (p = 0.0055) in Diphyllin apioside-
treated cells and up to 58.22% (p = 0.0019) following 
cell exposure to Diphyllin acetylapioside. The effects 
of Diphyllin apioside and Diphyllin acetylapioside 
were accompanied with a significant elevation in the 
percentage of late apoptotic population (Annexin 
V-positive/ PI-positive cells) reaching 27.46% 
Figure 3: Cell-cycle analysis of human melanoma A375 cells exposed to GI50 concentrations of of Diphyllin derivatives 
at 48h. Cell distribution at different stages was analysed by measuring the DNA content using flow cytometry. Data are shown as mean 
±SD (n=3). Pac= paclitaxel (positive control).
Oncotarget6www.impactjournals.com/oncotarget
(p = 0.0366) and 27.92% (p = 0.0095). Less than 
10% of population showed necrotic signs (Annexin 
V-negative/ PI-positive) after exposure to all 
compounds. Shorter incubations (12h) did not show any 
sign of early apoptosis (See Supplementary Figure 1 in 
Supplementary Materials).
Morphological changes induced by Diphyllin 
derivatives on A375 cells
The viability of A375 cells treated with 
GI50 concentrations of Diphyllin derivatives were 
qualitatively evaluated using phase contrast microscope 
Figure 4: Flow cytometry analysis of human melanoma A375 cells stained with Annexin V-FITC/PI after exposure to 
GI50 concentrations of Diphyllin derivatives during 24h. Data are shown as mean ±SD (n=3) of the percentage of unstained, single 
stained (Annexin-V-FITC or PI) and double stained cell population. CPT= camptothecin (positive control).
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and double staining with Hoechst 33342 and NucGreen® 
-that stains cells with compromized membranes. The 
results shown in Figure 5 confirmed those obtained 
from SRB assay: in contrast to control cells, cells 
treated with any of the Diphyllin derivatives showed a 
shrinkage in size, round in shape and disruption of cells 
attachment accompanied with characteristic features of 
apoptotic death such as formation of apoptotic bodies 
and membrane blebbing and nuclear fragmentation as 
revealed by a strong blue fluorescence.
Figure 5: Microscopy analyses of human melanoma A375 cells after exposure to GI50 concentrations of Diphyllin 
derivatives during 48h. (A) Live cell micrographs (fluorescence, 40x) of cells stained with Hoechst 33342 and NucGreen® Dead 
reagent (arrow indicates nuclear fragmentation). (B) Morphological changes observed (phase contrast microscope, 40x). Bar = 100 μm.
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Differential onset of caspase-3/7 activity after 
treatment with Diphyllin derivatives
In an attempt to assess whether the inhibitory effects 
on cell proliferation associated with effects on caspase-
mediated apoptosis pathway, caspase-3/7 activity was 
measured. As shown in Figure 6A, Diphyllin methyl ether 
induced significantly the activity of caspase-3/7 in a time-
dependent manner following 24, 48 and 72h exposure by 
2.67 fold (p = 0.0297), 2.85 fold (p = 0.0375) and 1.60 fold 
(p = 0.0048), respectively. However, in case of Justicidin 
B treatment there was no significant change detected at 
24, 48h periods whereas the activity of caspase-3/7 was 
significantly induced after 72h treatment by 1.72 fold (p = 
0.0366). The results indicated that there was no difference 
between untreated and treated cells with glycosylated 
derivatives after 24 treatment but it was significantly 
induced within 48h exposure to Diphyllin apioside and 
Diphyllin acetylapioside by 4.36 fold (p = 0.0475) and 
2.93 fold (p = 0.0351), respectively. Similar effect was 
detected at 72h incubation period reaching 1.8 fold (p = 
0.0260) for Diphyllin apioside and 2.49 fold (p = 0.0318) 
for Diphyllin acetylapioside treatments.
Bax and Bcl-2 expression in the presence of 
different Diphyllin derivatives
In this work, we aim to further gain insight into 
the expression of Bcl-2 family core members, Bax and 
Bcl-2, and assess the mitochondrial activation caused 
by these compounds after A375 cells were exposed for 
48h to GI50 concentrations of Diphyllin derivatives. 
As shown in Figure 6C, densitometry of the distinctive 
bands corresponding to Bax (20 kDa) and Bcl-2 (26 
kDa) demonstrated a significant increase in the protein 
expression of Bax after treatment with Diphyllin methyl 
ether (p = 0.0001) normalised to β-actin (45 kDa). 
Contrary to the increase of the Bax expression, the level 
of the anti-apoptotic factor Bcl-2 was markedly reduced 
(p = 0.0470). This resulted in a significant elevation of 
the ratio of Bax/Bcl-2 (p = 0. 0196) compared to that of 
the control in favour of apoptosis in A375 cells. However, 
the examination of those exposed to justicidin B showed 
no significant changes in expression of Bcl-2 whereas 
the level of Bax was markedly elevated (p = 0.0065) in 
comparison to their controls, therefore the ratio of Bax/
Bcl-2 was significantly increased (p = 0.0016).
In cells treated with Diphyllin apioside and 
Diphyllin acetylapioside, the expression of Bax protein 
was significantly upregulated (p = 0.0090) and (p = 
0.0378), respectively. Interestingly, the level of Bcl-2 
remained the same as untreated cells, however Bax/Bcl-
2 ratio was markedly changed (p = 0.0079, Diphyllin 
apioside) and (p = 0.0037, Diphyllin acetylapioside) 
demonstrating the elevation of Bax/Bcl-2 ratio.
Cytotoxicity of the studied Diphyllin derivatives 
is not affected by inhibitors of the MDR1/Pgp
Previous reports pointed towards Diphillyn as 
a substrate of P-glycoprotein (MDR1/P-gp) [7], thus 
potentially limiting its therapeutic potential. This 
prompted us to test their in vitro cytotoxicity on the 
melanoma cell line SK-Mel-5, reported to be one of the 
melanoma lineages expressing higher levels of the ABCB1 
transcript [22], both alone and in the presence of non toxic 
concentrations of verapamil, a known Pgp inhibitor widely 
used in cancer research [23]. The results are presented in 
Table 1. In line with the data from Szakács et al. [22]: 
treatment of Sk-Mel-5 cells with Vincristine, a cytotoxic 
drug known to be effluxed by MDR1/Pgp is predictably 
affected by co-treatment with 2.3 μM Verapamil, whilst 
Camptothecin did not. The diphyllin derivatives did not 
have their GI50 values significantly affected by the co-
treatment.
DISCUSSION
Justicidin B and the three tested Diphyllin 
4-derivatives significantly suppress the proliferation of 
human melanoma A375 cells in a time and concentration 
dependent manner. The antiproliferative activity of these 
compounds seems not to be influenced by MDR1/Pgp 
efflux as per our results in a functional assay (Table 1). 
Justicidin B induces an elevation in sub-G1 population 
within 48h with all morphological changes associated 
with apoptosis (blebbing, apoptotic bodies, nuclear 
fragmentation and externalization of phosphatidylserine). 
Activation of caspase-3/7 is evident only after 72h, 
thus pointing towards an initial caspase-independent 
mechanism of action driven by the elevated Bax levels 
after 48h that tilt the Bax/Bcl-2 ratio towards the 
release of pro-apoptotic molecules from mitochondria. 
Methoxylation in position 4 changes the dynamics by 
which Justicin B triggers apoptosis in A375 melanoma 
cells. The methyl ether derivative exerts the same effects 
of the parent molecule –albeit at a marginally higher 
GI50 (3.66 μM vs. 1.70 μM)- with a significant activation 
of caspase-3/7 within 24h, and a reduction of Bcl-2 
expression which further increases the Bax/Bcl-2 ratio.
Phosphatidylserine externalization and DNA 
fragmentation may occur independently of caspase 
action [24]. Luo’s group has reported that justicidin B 
translocated phosphatidylserine to the outer membrane 
of the human leukemia cell line (K562) indicating early 
apoptosis similar to A375 cells in this study [17]. Similar 
effect for Diphyllin methyl ether was demonstrated in 
other reports in which the proportion of apoptotic cells 
with externalized phosphatidylserine was elevated in 
human colorectal cancer cells (HT-29 and HCT 116) 
[12] and human hepatoma cells [11]. Whether caspase-
independent death effectors such apoptosis-inducing 
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factor (AIF) [25] and endonuclease G [26] may or not be 
activated by this compound warrant further attention. But 
caspase dependent mechanism was clearly implicated in 
the DNA fragmentation in MCF-7 and MDA-MB-231 
breast cancer after 24h as this proapoptotic activity was 
completely inhibited by the non-selective pan-caspase 
inhibitor Boc-Asp(OMe)-fluoromethyl ketone. However, 
Justicidin B exerted different effects in the two cell lines 
Figure 6: (A) Caspase-3/7 activity in human melanoma A375 cells treated with GI50 of Diphyllin and derivatives at different incubation 
periods (24, 48 and 72h). Pac= paclitaxel (positive control). (B) Densitometric evaluation of the expression levels of Bax/Bcl-2 proteins 
normalised to β-actin and changes in Bax/Bcl-2 ratio, CPT= camptothecin (positive control). (C) Immunoblot images of their expression in 
human melanoma A375 cells after 48h treatment with GI50 of Justicidin B, Diphyllin methyl ether (DiME), Diphyllin apioside (DiA), and 
Diphyllin acetylapioside (DiAA). Data are presented as the mean ±SD (n=3).
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increasing and decreasing the expression of NF-κB, 
respectively. This highlighting that Justicidin B may act 
by different mechanisms depending on the cancer cell 
line no matter how similar they are. A robust activation of 
caspase-3/7 by Diphyllin methyl ether in other cell lines 
was similarly reported by Won et al, in human hepatoma 
cells [27] but other caspases have been reported to be 
activated in response to Diphyllin methyl ether treatment 
such as caspase-8 in human hepatoma Hep 3B and Hep G2 
cells [11]. In addition, caspase-9 was activated in HT-29 
and HCT 116 colorectal cancer cells, eventually leading to 
translocation of Bax from the cytosol to mitochondria to 
induce apoptosis [12].
The glycosilation of the hydroxyl in position 4 
with apioside, a bulkier, more polar group, brings about 
a sizeable reduction of the GI50 down to nM ranges but 
delays activation of caspase-3/7 with respect to Diphyllin 
methyl ether. Further acetylation of the apioside halves 
the GI50 of the glycosylated Diphyllin and improves its 
selectivity against normal cells by 8 fold.
This study reiterates that the anti-proliferative 
activity of Diphyllin derivatives linked to a pronounced 
S phase arrest. As DNA is replicated once during the 
S-phase, the arrest of cell distribution at this phase results 
in the status where cells neither go forward nor retreat to 
G1 stage [28]. Moreover, the first symptom of apoptosis 
induction by these compounds is the accumulation of cells 
at sub-G1 peak which is considered as a biomarker for 
DNA fragmentation to low molecular weight in which 
cells manifest with a reduced DNA content. Diphyllin 
methyl ether, also caused elevations in the sub-G1 fraction 
in human hepatoma cells [11], colon colorectal cells [12]. 
In addition, Justicidin B has shown in literature an increase 
in the level of the apoptotic DNA fragmentation in human 
leukemia cell lines (HL-60) [13] and K562 [17].
As previously mentioned in the introduction, 
Diphyllin has been traditionally regarded as having a 
negative selectivity. However, in the case of Justicidin B 
there was only one study evaluating the selectivity of this 
lignan against Jurkat cells and PBMC where a nonspecific 
cytotoxicity was detected [29]. In our hands, it displayed 
at least 10 fold higher GI50 to HDF-a cells than the GI50 to 
human melanoma A375 cells. The GI50 concentration of 
Diphyllin methyl ether towards HDF-a was 7 fold higher 
compared to the GI50 for cancer cells thus showing similar 
selectivity to paclitaxel (positive control). Su et al., have 
reported similar effect where higher GI50 was about 10 fold 
towards non-malignant Chang liver cells [11]. Moreover, 
Diphyllin methyl ether had low toxicity in normal human 
peripheral blood mononuclear cells (PBMC) and human 
embryonic kidney cells (HEK293) up to 500, 100 fold, 
respectively, compared to cancer cells [12, 30]. Diphyllin 
acetylapioside had two times (8 fold) more selectivity 
compared to the parent molecule (4 fold).
Bcl-2 family is a crucial mediator of mitochondria-
dependent pathway controlling mitochondrial outer 
membrane permeabilization through the interactions 
between pro-apoptotic (Bax) and anti-apoptotic (Bcl-
2) core members [31, 32]. The higher Bax/Bcl-2 ratio 
is, the high is the cell susceptibility to apoptosis which 
is another indicator that Diphyllin methyl ether induced 
cellular apoptosis by targeting the intrinsic pathway. The 
explanation of how Diphyllin methyl ether impaired the 
mitochondria at 48h exposure could be that Bcl-2 protein 
is down regulated and thus unable to control Bax which 
was up-regulated. Consequently, transition pores of 
mitochondrial membrane increase in size and become 
large enough allowing cytochrome c to be released from 
the mitochondria which is essential for caspase activation 
[32]. In agreement with these findings, Lee et al., and 
Su et al., have mentioned the ability of Diphyllin methyl 
ether to reduce Bcl-xL expression and increase Bax and 
Bak level in hepatoma and colorectal cancer cells [11, 
12]. In vivo studies have been conducted showing the 
oral administration of Diphyllin methyl ether suppressed 
the growth of hepatoma cells and colorectal cancer cells 
implanted in NOD-SCID mice [11, 12].
In cells treated with Justicidin B, Diphyllin 
apioside and Diphyllin acetylapioside, only Bax protein 
expression was increased after 48h exposure and such an 
effect on Bcl-2 family has not been reported previously. 
Involvement of Bax protein in the mechanism of action of 
these lignans reveals the role of mitochondrial impairment 
in cell death and that was detected with or without the 
Table 1: Values of growth inhibition 50% of reference cytotoxic drugs and diphyllin derivatives in Sk-mel-5 cells co-
incubated with or without the MDR1/Pgp inhibitor verapamil (n = 3)
+ vehicle + verapamil (2.3µM)
Vincristine 1.04±0.90 nM 0.15±0.02 nM (p <0.01)
Camptothecin 6.93±1.51 nM 7.22±2.15 nM
Diphyllin methyl ether 2.33±0.24 µM 2.49±0.51 µM
Justicidin B 1.15±0.26 µM 1.22±0.23 µM
Diphyllin apioside 0.050±0.016 µM 0.046±0.045 µM
Diphyllin acetylapioside 0.045±0.008 µM 0.040±0.015 µM
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involvement of caspase, as mentioned above for Diphyllin 
apioside and Diphyllin acetylapioside as well as justicidin 
B, respectively. Bax has been reported to have a direct 
effect on both caspase dependent and independent 
pathways in which Bax activation and its translocation 
from cytosol to mitochondria triggers the release of 
cytochrome c, which is essential for caspase activity, AIF 
and endonuclease G causing DNA fragmentation and 
chromatin condensation [33] which could explain how 
these compounds works as pro-apoptotic agents in A375 
cells.
In summary, we here evidence that 4-methoxylation 
or 4-O-glycosylation of Justicidin B -a caspase 
independent mitochondrial apoptosis-inducer- differently 
triggers the onset of caspase-3/7 activation (24h vs. 48h, 
respectively). Interestingly, the methoxylation causes 
attenuation of Bcl-2 protein expression contrarily to 
the parent molecule or the O-glycosylated derivatives. 
If we take together our results and those from Luo’s 
structure-activity relationship study [17], there is a a 
possibility to dramatically increase the cytotoxicity of 
Justicidin B when this is glycosylated at position 4 of 
ring B and hydroxylated at position 6 of ring D. These 
considerations may inform future synthesis of Diphyllin 
derivatives with improved cytotoxicity and selectivity 
towards cancer cells.
MATERIALS AND METHODS
Chemicals
Diphyllin methyl ether (Justicidin A), Justicidin 
B, Diphyllin apioside (tuberculatin) and Diphyllin 
acetylapioside (tuberculatin acetate) were isolated from 
Haplophyllum tuberculatum as previously described [34]. 
The following were purchased from Sigma-Aldrich (St. 
Louis, MO, USA): Sulforhodamine B, trichloroacetic 
acid, Trizma base, propidium iodide (PI), Ribonuclease 
A (RNase). Glacial acetic acid, ethanol, methanol and 
chloroform were obtained from Fisher (Leicestershire, 
UK). TrypLE Express (1×, trypsin, EDTA, phenol red), 
phosphate-buffered saline (PBS) and trypan blue were 
purchased from Thermo Fisher Scientific (MA, USA).
Cell lines
The cytotoxicity and the selectivity of all 
compounds were evaluated using A375 and SK-Mel-5 
human melanoma cell (ATCC, American Type Culture 
Collection, Manassas, VA, USA) and human dermal 
fibroblasts (HDF-a, Thermo Fisher Scientific, MA, USA), 
respectively. The medium used to maintain A375 cells 
was Dulbecco’s Modified Eagle’s Medium (DMEM, 
Gibco) with 10% heat-inactivated fetal bovine serum 
(FBS, Gibco) and 1% of antibiotic solution (10,000 U/
mL, Penicillin-Streptomycin, Gibco). HDF-a cells were 
grown in MEM supplemented with 10% FBS, 1% MEM 
non-essential amino acids solution (NEAA, Gibco) and 
Gentamicin/Amphotericin Solution (5 mg/mL Gentamicin, 
125 μg/mL Amphotericin B, Gibco). SK-Mel-5 cells 
were maintained in Eagle’s Minimum Essential Medium 
(ATCC, VA, USA) with 10% FBS and 1% of antibiotic 
solution (10,000 U/mL, Penicillin-Streptomycin). All cell 
lines were cultured in complete growth medium (10% 
FBS) and incubated in an incubator with humidified air 
5% CO2 and atmosphere at 37°C.
Cell proliferation assay
The anti-proliferative activity of the compounds 
in tumor and normal cells was assessed by the 
sulforhodamine B (SRB) assay as previously described 
[35]. Cells were seeded into 96-well plates in the density 
of 1×104/well and incubated overnight. After 24h, medium 
was removed and replaced with complete growth medium 
supplemented with different concentrations of the 
compounds for 24, 48 and 72h then assayed for growth 
inhibition using SRB method. Adherent cells were fixed 
by the addition of cold 40% (w/v) trichloroacetic acid to 
achieve a final concentration of 10% and incubated for 
1h at 4°C. The plates were washed with deionised water 
and SRB solution (4 % SRB in 0.1% acetic acid) was 
added and incubated for 30 mins at room temperature. 
Unbounded stains were removed by washing plates with 
1% acetic acid. The bounded stain was later solubilized 
with 10 mM Trizma base buffer and absorbance was 
measured (Infinite® M200, Tecan, Switzerland), data 
normalized to untreated wells, GI50 value was calculated as 
the concentration that results in 50% cell growth inhibition 
and graphs were drawn on OriginPro software (version 
9.3.1.273).
Cell cycle analysis
Cell cycle distribution was analysed by measuring 
the DNA content using flow cytometry as previously 
mentioned [36]. When A375 cells reach 70% confluence, 
they were plated at low-serum medium (2%FBS) at a 
density of 2.5×105 cells/well in 6-well plates. After 24h, 
they were incubated with the compounds in complete 
growth medium for 48h. Then, cells were harvested by 
trypsinization and also the floating cells in the medium 
was collected. They were pelleted by centrifugation, 
washed twice with PBS, resuspended in ice-cold 70% 
ethanol in PBS for fixation and kept at 4°C for 24h. 
Prior analysis, fixed cells were washed with PBS and 
incubated with PI staining solution containing 100μg/
mL of RNase and 50μg/mL of PI in PBS in the dark for 
30 mins. Cellular DNA content was analysed by FACS 
analysis using The MACSQuant® Analyzer 10 and 
MACSQuantify software (Miltenyi Biotec, Germany) 
for cell cycle analyses. The results were expressed as 
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the percentage of cell population in each phase (mean 
± SD, n = 3).
Flow cytometry analyses for apoptosis induction
Analysis of the translocation of phosphatidylserine 
to the outer leaflet of cell membrane was performed 
according to the manufacturer’s instructions (Annexin 
V-FITC Kit, Miltenyi Biotec, Germany). Briefly, 1×105 
A375 cells were seeded in 12-well plates overnight and 
treated with the compounds for 24h. Cells were washed 
with PBS and the binding buffer and then resuspended in 
the binding buffer containing 10 μL of Annexin V-FITC 
for 15mins in the dark. After washing the cells with 
binding buffer again, they were incubated with 1μg/mL 
of PI in binding buffer prior to analysis by FACS. Data 
acquisition was performed using The MACSQuant® 
Analyzer 10 and MACSQuantify software (Miltenyi 
Biotec, Germany) for data analysis. Data was shown as 
the percentage of unstained/single or double stain cells in 
four populations (mean ± SD, n = 3).
Cellular morphology by phase contrast 
microscope and cell viability imaging by 
fluorescence microscope
Morphological assessment of A375 cells was 
performed to detect the cellular changes induced by the 
tested compounds according to the method with slight 
modifications [37]. Briefly, 1×104 cells were treated 
with or without the compounds in a sterile chamber slide 
system (Nunc™ Lab-Tek™ II Chamber Slide™ System) 
for 48h. Prior cellular examination, the media was 
removed and replaced with PBS. Treated cells with typical 
morphological changes of apoptosis were imaged using 
phase contrast inverted microscope (EVOS cell imaging 
system, Thermo Fisher Scientific, MA, USA).
A375 cells were examined with fluorescence 
microscope using ReadyProbes® cell viability imaging kit 
according to manufacturer’s recommendations (Thermo 
Fisher Scientific, MA, USA). A375 cells were treated in 
the same condition as mentioned in the previous section. 
Both dyes were added for 15 mins and slides were 
visualised using EVOS cell imaging system (Thermo 
Fisher Scientific).
Caspase-3/7 activity assay
Luminescent caspase-Glo 3/7 assay was carried out 
on exposed cells to Diphyllin and its derivativesaccording 
to the manufacturer’s instructions (Promega, WI, USA). 
A375 cells were seeded in white 96-well plates and treated 
with the cytotoxic compounds for 24, 48 and 72h. The 
cells were incubated with caspase-Glo 3/7 reagent for 1 h 
at room temperature which was followed by measuring the 
enzymatic activity of caspase through luminescent signal 
using microplate reader (Infinite® M200, Tecan).
Western blot analysis
Whole-cell extracts were prepared and analysed 
by Western blot kit according to manufacturer’s 
recommendation (Cell Signaling Technology, MA, 
USA). After A375 cells were treated with the Diphyllin 
for 48h, they were lysed with lysis buffer and sonicated 
and then the cell extract was centrifuged. The protein 
concentration was quantified using BCA kit (Cell 
Signaling Technology) as described by the manufacturer. 
The protein extracts (50μg) were suspended in the 
loading buffer after heating to 95°C. They were loaded 
to standard SDS-PAGE (12% Tris-Glycine, BioRad, 
Herts, UK), along with prestained protein marker (11-
190 kDa) and biotinylated protein ladder to detect the 
molecular weight ladders and electrophoresis was carried 
out at 110 for 95 mins (PowerPac™ Basic power Bio-
Rad, California, USA). The gel was transferred onto 
nitrocellulose membrane and then it was blocked in 
blocking buffer, 5% non-fat dry milk in 1X Tris Buffered 
Saline with Tween 20. This was followed by probing the 
membrane with Bax, Bcl-2 and β-actin proteins (Cell 
Signaling Technology, MA, USA), the later was used as 
a standard for the amount of the loaded protein (50μg) 
in each lane. The bound primary antibody complex and 
biotinylated protein marker were then stained using 
horseradish peroxidase-conjugated anti-mouse, anti-
rabbit, and anti-biotin secondary antibodies. Protein 
bands were detected with enhanced chemiluminescence 
reagents and visualised by GeneGnome for 
chemiluminescence imaging (Syngene Bio Imaging, 
Frederick, MD, USA) using GENESys (version 1.3.3.0). 
Data was expressed as the ratio of Bax and Bcl-2 that 
was normalized to β-actin (n = 3). Densitometric 
evaluation of the percent change in expression levels of 
Bax/Bcl-2 proteins was carried out using GelQuantNET 
(version 1.8.2).
Statistical analysis
Results are expressed as mean ± standard deviation 
(SD) from at least three independent experiments. All data 
were analysed using unpaired two-tailed Student’s t-test 
with a p value of <0.05 considered as significant to find 
the statistical significance between treated groups and 
controls.
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